Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
about
Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?Power frequency magnetic field promotes a more malignant phenotype in neuroblastoma cells via redox-related mechanisms.Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells.Radiation-mediated tumor growth inhibition is significantly enhanced with redox-active compounds that cycle with ascorbate.Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway.Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis.Extremely Low-Frequency Magnetic Fields and Redox-Responsive Pathways Linked to Cancer Drug Resistance: Insights from Co-Exposure-Based In Vitro Studies.
P2860
Q38694717-82A6A8CA-EFED-485B-AA2E-5E73AF6233C7Q41126084-59EBB8AC-E2DA-4B43-8247-BCD67BA86DF0Q47094256-F5B53314-AFBC-4129-B990-8532ADD2FEB5Q49484285-423C0DF4-6660-43EA-8CB5-A001AA9F27AFQ49874471-0EB86220-5538-425D-8D23-8CF05F95131BQ50098904-7C2226E4-0A02-4062-BF35-B4C2D03AB02CQ55107351-E6249CEA-A9D7-4C08-AE2C-59559EE0BC66
P2860
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
@en
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
@nl
type
label
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
@en
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
@nl
prefLabel
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
@en
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
@nl
P2093
P2860
P1433
P1476
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
@en
P2093
Daiha Shin
Eun Hye Kim
Hyejin Jang
Jong-Lyel Roh
Seung Ho Baek
P2860
P2888
P304
P356
10.1007/S10495-016-1284-8
P577
2016-08-20T00:00:00Z